Market Overview

Barclays Morning Research Summary: Commodities, Comcast And Healthcare In Focus

Barclays Morning Research Summary: Commodities, Comcast And Healthcare In Focus

Barclays has downgraded Plains GP Holdings LP (NYSE: PAGP), while revising the price targets of Comcast Corporation (NASDAQ: CMCSA), Johnson & Johnson (NYSE: JNJ), Juno Therapeutics Inc (NASDAQ: JUNO) and Plains All American Pipeline, L.P. (NYSE: PAA).

The brokerage has downgraded Plains GP to Equal Weight from Overweight on dividend concerns. However, analyst Christine Cho raised the price target to $11 from $8.

Related Link: Plains GP Holdings Downgraded At Barclays On Dividend Concerns

Meanwhile, Barclays has raised the price target of Comcast to $69 (prior: $65), Johnson & Johnson to $125 (prior: $120) and Plains All American to $30 (prior: $23). The brokerage has an Overweight rating on Comcast and Johnson & Johnson, while remaining Equal Weight on Plains All American.

In addition, Barclays slashed the price target of Juno Therapeutics by 27 percent to $35 after it announced the death of two cancer patients in a mid-stage study of JCAR015. That said, the brokerage remains Equal Weighted on the stock.

Related Link: Juno Therapeutics Plunges 30% After 2 Patient Deaths From Lead Cancer Drug

"[W]e are lowering our PT on JUNO to $35 (from $48), reflecting a delay in approval on the ROCKET trial, lowered probability of success for this trial, and an higher discount rate - pending clarity on the potential impact on other programs," analyst Jonathan Eckard wrote in a note.

At Time Of Writing...

  • Plains GP shares were flat at $9.90.
  • Plains All American rose 1.30 percent to $27.18.
  • Comcast gained 0.47 percent to $66.57.
  • Johnson & Johnson were up 0.02 percent to $122.52.
  • Juno Therapeutics plunged 32.08 percent to $27.73.

Latest Ratings for CMCSA

Oct 2019Initiates Coverage OnMarket Perform
Oct 2019MaintainsBuy
Sep 2019Initiates Coverage OnBuy

View More Analyst Ratings for CMCSA
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech Downgrades Health Care Price Target Commodities Reiteration Markets Best of Benzinga


Related Articles (CMCSA + JNJ)

View Comments and Join the Discussion!

Latest Ratings

ELMDDougherty & Co.Initiates Coverage On12.0
MRNSCantor FitzgeraldAssumes7.0
MNRLCapital One FinancialInitiates Coverage On23.0
SONVertical GroupUpgrades
UNPMorgan StanleyMaintains136.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

USD/CAD Moves Up, Focus On BOC

Viad's GES Receives 4 Big F&E Contracts